Skip to main content
Top
Published in: BMC Nephrology 1/2021

Open Access 01-12-2021 | Obesity | Research

Association of elevated serum aminotransferase levels with chronic kidney disease measures: hispanic community health study/study of latinos

Authors: Celestin Missikpode, Holly Kramer, Scott J. Cotler, Ramon Durazo-Arvizu, James P. Lash, Eric Kallwitz, Jianwen Cai, Mark H. Kuniholm, Sylvia E. Rosas, Ana C. Ricardo, Gregory A. Talavera, Leopoldo Raij, Amber Pirzada, Martha L. Daviglus

Published in: BMC Nephrology | Issue 1/2021

Login to get access

Abstract

Background

Previous studies have shown an association between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD), but it is unclear whether the association is independent of metabolic syndrome.

Methods

Data from 13,006 participants aged 18 to 74 years in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) without viral hepatitis, excessive alcohol consumption, or high transferrin saturation levels were analyzed. Suspected NAFLD was defined as presence of sex-specific elevations in serum aminotransferase levels (aspartate aminotransferase (AST) > 37 U/L or alanine aminotransferase (ALT) > 40 U/L for men and AST or ALT > 31 U/L for women). Logistic regression was used to examine cross-sectional associations of elevated serum aminotransferase levels with low estimated glomerular filtration rate (eGFR < 60 ml/min/1.73 m2 based on cystatin C), and with high urinary albumin-to-creatinine ratio (UACR) (> 17 mg/g in men and > 25 mg/ g in women) in separate models adjusting for demographic characteristics and metabolic syndrome.

Results

Mean (SD) age was 41 (0.27) years, and 45 % were male. Elevated serum aminotransferase levels were noted in 18.8 % of the population and were associated with greater odds of high UACR (OR = 1.31; 95 % CI = 1.10, 1.56) after adjusting for demographic characteristics; this association became non-significant after adjustment for metabolic syndrome (OR = 1.11, 95 % CI = 0.92, 1.33). In contrast, elevated serum aminotransferase levels were not associated with low eGFR (odds ratio (OR) = 0.73; 95 % confidence interval (CI) = 0.45, 1.18) after adjusting for covariates.

Conclusions

In this sample of diverse U.S. Hispanic Latino adults, elevated serum aminotransferase levels were not independently associated with measures of CKD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Younossi, Z. M., Stepanova, M., Afendy, M., Fang, Y., Younossi, Y., Mir, H., & Srishord, M. (2011). Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clinical Gastroenterology and Hepatology, 9(6), 524–530.CrossRef Younossi, Z. M., Stepanova, M., Afendy, M., Fang, Y., Younossi, Y., Mir, H., & Srishord, M. (2011). Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clinical Gastroenterology and Hepatology, 9(6), 524–530.CrossRef
2.
go back to reference Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., … Hobbs, H. H. (2004). Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology, 40(6), 1387–1395.CrossRef Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., … Hobbs, H. H. (2004). Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology, 40(6), 1387–1395.CrossRef
3.
go back to reference Rich, N. E., Oji, S., Mufti, A. R., Browning, J. D., Parikh, N. D., Odewole, M., … Singal, A. G. (2018). Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology, 16(2), 198–210.CrossRef Rich, N. E., Oji, S., Mufti, A. R., Browning, J. D., Parikh, N. D., Odewole, M., … Singal, A. G. (2018). Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology, 16(2), 198–210.CrossRef
4.
go back to reference Lora, C. M., Daviglus, M. L., Kusek, J. W., Porter, A., Ricardo, A. C., Go, A. S., & Lash, J. P. (2009). Chronic kidney disease in United States Hispanics: a growing public health problem. Ethnicity & disease, 19(4), 466. Lora, C. M., Daviglus, M. L., Kusek, J. W., Porter, A., Ricardo, A. C., Go, A. S., & Lash, J. P. (2009). Chronic kidney disease in United States Hispanics: a growing public health problem. Ethnicity & disease, 19(4), 466.
6.
go back to reference Ricardo, A. C., Flessner, M. F., Eckfeldt, J. H., Eggers, P. W., Franceschini, N., Go, A. S., … Melamed, M. L. (2015). Prevalence and correlates of CKD in Hispanics/Latinos in the United States. Clinical Journal of the American Society of Nephrology, 10(10), 1757–1766.CrossRef Ricardo, A. C., Flessner, M. F., Eckfeldt, J. H., Eggers, P. W., Franceschini, N., Go, A. S., … Melamed, M. L. (2015). Prevalence and correlates of CKD in Hispanics/Latinos in the United States. Clinical Journal of the American Society of Nephrology, 10(10), 1757–1766.CrossRef
7.
go back to reference Targher, G., Bertolini, L., Chonchol, M., Rodella, S., Zoppini, G., Lippi, G., … Bonora, E. (2010). Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia, 53(7), 1341–1348.CrossRef Targher, G., Bertolini, L., Chonchol, M., Rodella, S., Zoppini, G., Lippi, G., … Bonora, E. (2010). Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia, 53(7), 1341–1348.CrossRef
8.
go back to reference Chang, Y., Ryu, S., Sung, E., Woo, H. Y., Oh, E., Cha, K., … Kim, W. S. (2008). Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism, 57(4), 569–576.CrossRef Chang, Y., Ryu, S., Sung, E., Woo, H. Y., Oh, E., Cha, K., … Kim, W. S. (2008). Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism, 57(4), 569–576.CrossRef
9.
go back to reference Mantovani, A., Zaza, G., Byrne, C. D., Lonardo, A., Zoppini, G., Bonora, E., & Targher, G. (2018). Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis. Metabolism, 79, 64–76.CrossRef Mantovani, A., Zaza, G., Byrne, C. D., Lonardo, A., Zoppini, G., Bonora, E., & Targher, G. (2018). Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis. Metabolism, 79, 64–76.CrossRef
10.
go back to reference Sirota, J. C., McFann, K., Targher, G., Chonchol, M., & Jalal, D. I. (2012). Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988–1994. American journal of nephrology, 36(5), 466–471.CrossRef Sirota, J. C., McFann, K., Targher, G., Chonchol, M., & Jalal, D. I. (2012). Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988–1994. American journal of nephrology, 36(5), 466–471.CrossRef
11.
go back to reference Sorlie, P. D., Avilés-Santa, L. M., Wassertheil-Smoller, S., Kaplan, R. C., Daviglus, M. L., Giachello, A. L., … LaVange, L. (2010). Design and implementation of the Hispanic community health study/study of Latinos. Annals of epidemiology, 20(8), 629–641.CrossRef Sorlie, P. D., Avilés-Santa, L. M., Wassertheil-Smoller, S., Kaplan, R. C., Daviglus, M. L., Giachello, A. L., … LaVange, L. (2010). Design and implementation of the Hispanic community health study/study of Latinos. Annals of epidemiology, 20(8), 629–641.CrossRef
12.
go back to reference LaVange, L. M., Kalsbeek, W. D., Sorlie, P. D., Avilés-Santa, L. M., Kaplan, R. C., Barnhart, J., … Criqui, M. H. (2010). Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos. Annals of epidemiology, 20(8), 642–649.CrossRef LaVange, L. M., Kalsbeek, W. D., Sorlie, P. D., Avilés-Santa, L. M., Kaplan, R. C., Barnhart, J., … Criqui, M. H. (2010). Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos. Annals of epidemiology, 20(8), 642–649.CrossRef
14.
go back to reference Kallwitz ER, Daviglus ML, Allison MA, Emory KT, Zhao L, Kuniholm MH, Youngblood ME. Prevalence of suspected nonalcoholic fatty liver disease in Hispanic/Latino individuals differs by heritage. Clinical Gastroenterology and Hepatology. 2015;13(3):569–76.CrossRef Kallwitz ER, Daviglus ML, Allison MA, Emory KT, Zhao L, Kuniholm MH, Youngblood ME. Prevalence of suspected nonalcoholic fatty liver disease in Hispanic/Latino individuals differs by heritage. Clinical Gastroenterology and Hepatology. 2015;13(3):569–76.CrossRef
15.
go back to reference Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006). The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC gastroenterology, 6(1), 1–7.CrossRef Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006). The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC gastroenterology, 6(1), 1–7.CrossRef
16.
go back to reference Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, Nelson M. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317–25.CrossRef Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, Nelson M. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317–25.CrossRef
17.
go back to reference Ciardullo, S., Sala, I., & Perseghin, G. (2020). Screening strategies for nonalcoholic fatty liver disease in type 2 diabetes: Insights from NHANES 2005–2016. Diabetes Research and Clinical Practice, 167, 108358.CrossRef Ciardullo, S., Sala, I., & Perseghin, G. (2020). Screening strategies for nonalcoholic fatty liver disease in type 2 diabetes: Insights from NHANES 2005–2016. Diabetes Research and Clinical Practice, 167, 108358.CrossRef
18.
go back to reference Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Coresh J. Estimating glomerular filtration rate from serum creatinine and cystatin C. New England Journal of Medicine. 2012;367(1):20–9.CrossRef Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Coresh J. Estimating glomerular filtration rate from serum creatinine and cystatin C. New England Journal of Medicine. 2012;367(1):20–9.CrossRef
19.
go back to reference Jacobs Jr, D. R., Murtaugh, M. A., Steffes, M., Yu, X., Roseman, J., & Goetz, F. C. (2002). Gender-and race-specific determination of albumin excretion rate using albumin-to-creatinine ratio in single, untimed urine specimens: the Coronary Artery Risk Development in Young Adults Study. American journal of epidemiology, 155(12), 1114–1119.CrossRef Jacobs Jr, D. R., Murtaugh, M. A., Steffes, M., Yu, X., Roseman, J., & Goetz, F. C. (2002). Gender-and race-specific determination of albumin excretion rate using albumin-to-creatinine ratio in single, untimed urine specimens: the Coronary Artery Risk Development in Young Adults Study. American journal of epidemiology, 155(12), 1114–1119.CrossRef
20.
go back to reference Mattix, H. J., Hsu, C. Y., Shaykevich, S., & Curhan, G. (2002). Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. Journal of the American Society of Nephrology, 13(4), 1034–1039.CrossRef Mattix, H. J., Hsu, C. Y., Shaykevich, S., & Curhan, G. (2002). Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. Journal of the American Society of Nephrology, 13(4), 1034–1039.CrossRef
21.
go back to reference Chobanian, A. V. (2003). National heart, lung, and blood institute joint national committee on prevention, detection, evaluation, and treatment of high blood pressure; national high blood pressure education program coordinating committee: the seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Jama, 289, 2560–2572.CrossRef Chobanian, A. V. (2003). National heart, lung, and blood institute joint national committee on prevention, detection, evaluation, and treatment of high blood pressure; national high blood pressure education program coordinating committee: the seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Jama, 289, 2560–2572.CrossRef
22.
go back to reference American Diabetes Association. (2016). 2. Classification and diagnosis of diabetes. Diabetes care, 39(Supplement 1), S13-S22. American Diabetes Association. (2016). 2. Classification and diagnosis of diabetes. Diabetes care, 39(Supplement 1), S13-S22.
23.
go back to reference Ashen, M. D., & Blumenthal, R. S. (2005). Low HDL cholesterol levels. New England Journal of Medicine, 353(12), 1252–1260.CrossRef Ashen, M. D., & Blumenthal, R. S. (2005). Low HDL cholesterol levels. New England Journal of Medicine, 353(12), 1252–1260.CrossRef
24.
go back to reference Kopin, L., & Lowenstein, C. J. (2017). Dyslipidemia. Annals of internal medicine, 167(11), ITC81-ITC96.PubMed Kopin, L., & Lowenstein, C. J. (2017). Dyslipidemia. Annals of internal medicine, 167(11), ITC81-ITC96.PubMed
25.
go back to reference Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes care. 2000;23(1):57–63.CrossRef Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes care. 2000;23(1):57–63.CrossRef
26.
go back to reference Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Hobbs HH. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nature genetics. 2008;40(12):1461–5.CrossRef Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Hobbs HH. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nature genetics. 2008;40(12):1461–5.CrossRef
27.
go back to reference National Cholesterol Education Program (NCEP). (2002). Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in Adults (Adult treatment Panel III). Third report of the National cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in Adults (Adult treatment Panel III) final report. Circulation, 106(25), 3143–3421.CrossRef National Cholesterol Education Program (NCEP). (2002). Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in Adults (Adult treatment Panel III). Third report of the National cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in Adults (Adult treatment Panel III) final report. Circulation, 106(25), 3143–3421.CrossRef
28.
go back to reference Caldwell, S. H., Ikura, Y., Iezzoni, J. C., & Liu, Z. (2007). Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?. Journal of gastroenterology and hepatology, 22, S11-S19.CrossRef Caldwell, S. H., Ikura, Y., Iezzoni, J. C., & Liu, Z. (2007). Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?. Journal of gastroenterology and hepatology, 22, S11-S19.CrossRef
29.
go back to reference Stefan, N., Kantartzis, K., & Häring, H. U. (2008). Causes and metabolic consequences of fatty liver. Endocrine reviews, 29(7), 939–960.CrossRef Stefan, N., Kantartzis, K., & Häring, H. U. (2008). Causes and metabolic consequences of fatty liver. Endocrine reviews, 29(7), 939–960.CrossRef
30.
go back to reference Edmison, J., & McCullough, A. J. (2007). Pathogenesis of non-alcoholic steatohepatitis: human data. Clinics in liver disease, 11(1), 75–104.CrossRef Edmison, J., & McCullough, A. J. (2007). Pathogenesis of non-alcoholic steatohepatitis: human data. Clinics in liver disease, 11(1), 75–104.CrossRef
31.
go back to reference Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003). Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology, 37(5), 1202–1219. Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003). Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology, 37(5), 1202–1219.
32.
go back to reference Ciardullo S, Ballabeni C, Trevisan R, Perseghin G. Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population. Dig Liver Dis. 2021;53:866–72. Ciardullo S, Ballabeni C, Trevisan R, Perseghin G. Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population. Dig Liver Dis. 2021;53:866–72.
33.
go back to reference Yeung MW, Wong GLH, Choi KC, Luk AOY, Kwok R, Shu SST, Kong APS. Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes. Journal of hepatology. 2018;68(1):147–56.CrossRef Yeung MW, Wong GLH, Choi KC, Luk AOY, Kwok R, Shu SST, Kong APS. Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes. Journal of hepatology. 2018;68(1):147–56.CrossRef
34.
go back to reference Vilar-Gomez E, Calzadilla-Bertot L, Friedman SL, Gra-Oramas B, Gonzalez-Fabian L, Villa-Jimenez O, Chalasani N. Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis. Alimentary pharmacology & therapeutics. 2017;45(2):332–44.CrossRef Vilar-Gomez E, Calzadilla-Bertot L, Friedman SL, Gra-Oramas B, Gonzalez-Fabian L, Villa-Jimenez O, Chalasani N. Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis. Alimentary pharmacology & therapeutics. 2017;45(2):332–44.CrossRef
35.
go back to reference Huang, Y., Cohen, J. C., & Hobbs, H. H. (2011). Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. Journal of Biological Chemistry, 286(43), 37085–37093.CrossRef Huang, Y., Cohen, J. C., & Hobbs, H. H. (2011). Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. Journal of Biological Chemistry, 286(43), 37085–37093.CrossRef
36.
go back to reference Kollerits B, Coassin S, Kiechl S, Hunt SC, Paulweber B, Willeit J, Kronenberg F. A common variant in the adiponutrin gene influences liver enzyme values. J Med Genetics. 2010;47(2):116–9.CrossRef Kollerits B, Coassin S, Kiechl S, Hunt SC, Paulweber B, Willeit J, Kronenberg F. A common variant in the adiponutrin gene influences liver enzyme values. J Med Genetics. 2010;47(2):116–9.CrossRef
37.
go back to reference Yuan X, Waterworth D, Perry JR, Lim N, Song K, Chambers JC, Bergmann S. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. The American Journal of Human Genetics. 2008;83(4):520–8.CrossRef Yuan X, Waterworth D, Perry JR, Lim N, Song K, Chambers JC, Bergmann S. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. The American Journal of Human Genetics. 2008;83(4):520–8.CrossRef
38.
go back to reference Sookoian, S., & Pirola, C. J. (2011). Meta-analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology, 53(6), 1883–1894.CrossRef Sookoian, S., & Pirola, C. J. (2011). Meta-analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology, 53(6), 1883–1894.CrossRef
39.
go back to reference Li Q, Qu HQ, Rentfro AR, Grove ML, Mirza S, Lu Y, ... & McCormick JB. PNPL A3 polymorphisms and liver aminotransferase levels in a Mexican American population. Clin Invest Med. Medecine clinique et experimentale. 2012;35(4):E237. Li Q, Qu HQ, Rentfro AR, Grove ML, Mirza S, Lu Y, ... & McCormick JB. PNPL A3 polymorphisms and liver aminotransferase levels in a Mexican American population. Clin Invest Med. Medecine clinique et experimentale. 2012;35(4):E237.
40.
go back to reference Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, Choi KM. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology. 2014;59(5):1772–8.CrossRef Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, Choi KM. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology. 2014;59(5):1772–8.CrossRef
41.
go back to reference Adams, L. A., & Lindor, K. D. (2007). Nonalcoholic fatty liver disease. Annals of epidemiology, 17(11), 863–869.CrossRef Adams, L. A., & Lindor, K. D. (2007). Nonalcoholic fatty liver disease. Annals of epidemiology, 17(11), 863–869.CrossRef
42.
go back to reference Maximos M, Bril F, Portillo Sanchez P, Lomonaco R, Orsak B, Biernacki D, Cusi K. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease. Hepatology. 2015;61(1):153–60.CrossRef Maximos M, Bril F, Portillo Sanchez P, Lomonaco R, Orsak B, Biernacki D, Cusi K. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease. Hepatology. 2015;61(1):153–60.CrossRef
43.
go back to reference Clark, J. M., Brancati, F. L., & Diehl, A. M. (2003). The prevalence and etiology of elevated aminotransferase levels in the United States. The American journal of gastroenterology, 98(5), 960–967.CrossRef Clark, J. M., Brancati, F. L., & Diehl, A. M. (2003). The prevalence and etiology of elevated aminotransferase levels in the United States. The American journal of gastroenterology, 98(5), 960–967.CrossRef
Metadata
Title
Association of elevated serum aminotransferase levels with chronic kidney disease measures: hispanic community health study/study of latinos
Authors
Celestin Missikpode
Holly Kramer
Scott J. Cotler
Ramon Durazo-Arvizu
James P. Lash
Eric Kallwitz
Jianwen Cai
Mark H. Kuniholm
Sylvia E. Rosas
Ana C. Ricardo
Gregory A. Talavera
Leopoldo Raij
Amber Pirzada
Martha L. Daviglus
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2021
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-021-02483-y

Other articles of this Issue 1/2021

BMC Nephrology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.